Evidence map›Paper›PMID 9716405›Full record

ArticleGenes & development1998

The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms.

A Moreira, Y Takagaki, S Brackenridge, M Wollerton, J L Manley, N J Proudfoot

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 156 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

A MoreiraSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
Y Takagaki
S Brackenridge
M Wollerton
J L Manley
N J Proudfoot
Instituto de Biologia Molecular e CelularUniversidade do Porto · PTColumbia University · USUniversity of Cambridge · GB

Funding

MRNA SYTHESIS IN ANIMAL CELLS--3END FORMATIONR01GM028983 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI MANLEY, JAMES L. · 1985 to 2014
$6.4M
NIGMS NIH HHS GM 28983NIGMS NIH HHS R01 GM028983Wellcome Trust
6 · The paper itself

Abstract

The poly(A) signal of the C2 complement gene is unusual in that it possesses an upstream sequence element (USE) required for full activity in vivo. We describe here in vitro experiments demonstrating that this USE enhances both the cleavage and poly(A) addition reactions. We also show that the C2 USE can be cross-linked efficiently to a 55-kD protein that we identify as the polypyrimidine tract-binding protein (PTB), implicated previously in modulation of pre-mRNA splicing. Mutation of the PTB-binding site significantly reduces the efficiency of the C2 poly(A) site both in vivo and in vitro. Furthermore, addition of PTB to reconstituted processing reactions enhances cleavage at the C2 poly(A) site, indicating that PTB has a direct role in recognition of this signal. The C2 USE, however, also increases the affinity of general polyadenylation factors independently for the C2 poly(A) signal as detected by enhanced binding of cleavage-stimulaton factor (CstF). Strikingly, this leads to a novel CstF-dependant enhancement of the poly(A) synthesis phase of the reaction. These studies both emphasize the interconnection between splicing and polyadenylation and indicate an unexpected flexibility in the organization of mammalian poly(A) sites.

Indexed as

Binding SitesComplement C2HumansmRNA Cleavage and Polyadenylation FactorsMutationPoly APolypyrimidine Tract-Binding ProteinPromoter Regions, GeneticRecombinant ProteinsRibonucleoproteinsRNA-Binding ProteinsRNA, MessengerRNA SplicingTranscriptional ActivationComplement C2mRNA Cleavage and Polyadenylation FactorsPoly APolypyrimidine Tract-Binding ProteinRecombinant ProteinsRibonucleoproteinsRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID9716405
PMCPMC317083
OpenAlexW2098410794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.